Dear Authors,
If you believe that your paper was mistakenly rejected by other leading journals and you do not agree with final decision, the editors of Reports of Practical Oncology and Radiotherapy offer new fast track review. You may submit your manuscript to Reports of Practical Oncology and Radiotherapy together with all prior peer-reviews obtained from the other journal and your rebuttal letter. We guarantee review based decision within 72 hours from the time we will receive your manuscript.

Fast track submission process: Please submit the manuscript with all reviews and rebuttal letter by email to Dr. Michal Masternak ( for fast review processing. To assure immediate attention the email title must to include: RPOR-fast track- Last Name First Name (of corresponding author).

Volume 6, Number 1, 2001

Stereotactic radiotherapy for primary and recurrent brain tumors. A new method for improvement of the treatment results?

Fijuth J.


To evaluate the effectiveness of the stereotactic radiosurgery (SRS) and stereotactic fractionated radiotherapy in the primary, recurrent and metastatic brain tumors.

To present potential usefulness of stereotactic boost in anaplastic astrocytomas (AA) and glioblastoma multiforme (GBM).

Between March 2000 and December 2000, SRS was applied in 23 patients (pts) with brain tumors (metastatic tumors - 9 pts, recurrent tumors - 7 pts, primary meningiomas - 4 pts, vascular malformations - 3 pts).

Fractionated stereotactic radiotherapy was applied in 6 pts (recurrent anaplastic gliomas - 2 pts, recurrent medulloblastoma - 1 pt, acustic neurinoma - 1 pt, meningioma - 1, pituitary adenoma - 1).

Detailed technique of treatment planning is presented and discussed. The planning target volume (PTV) and organs at risk (OAR) were assessed comparing dose statistics, dose volume histograms and RTOG stereotactic radiosurgery criteria.

Recommendations regarding the total dose level and fractional dose are proposed.

The treatment tolerance and preliminary results are presented.

The own protocol of stereotactic boost to residual tumor using SRS after initial conformal radiotherapy in patients with AA and GBM is presented and discussed.

Signature: Rep Pract Oncol Radiother, 2001; 6(1) : 56-56

« back


Indexed in: EMBASE®, the Excerpta Medica database, the Elsevier BIOBASE (Current Awareness in Biological Sciences) and in the Index Copernicus.